Tech Transfer Roundup: Neon Licenses NKI IP To Advance Cell Therapy Into Clinic

 
• By Joseph Haas, Beth Allan, Deanna Kamienski, and Maureen Riordan

Continuing a partnership between Neon co-founder and two Netherlands Cancer Institute researchers, agreement will help autologous T-cell candidate move into Phase I. Plus Scrip's monthly roundup of tech transfer deals.

Tech Transfer regular column feature image

More from Deals

More from Business